The Board of Directors of drug manufacturer Biofarm (stock symbol: BIO) has convened the general meeting of shareholders on April 28 to vote on distributing dividends in the amount of RON41.4 million, namely, 41% of the company's 2025 net profit of RON100 million.
The military crisis in the Middle East is starting to increasingly take its toll on the Romanian business environment where entrepreneurs expect cost increases, dwindling sales and additional pressure on profitability, as per an IMM Romania survey conducted among more than 1,430 companies.